These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35791965)

  • 1. Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia.
    Frankle WG; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2022 Nov; 92(10):791-799. PubMed ID: 35791965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
    Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
    Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopamine release in schizophrenia comorbid with substance dependence.
    Thompson JL; Urban N; Slifstein M; Xu X; Kegeles LS; Girgis RR; Beckerman Y; Harkavy-Friedman JM; Gil R; Abi-Dargham A
    Mol Psychiatry; 2013 Aug; 18(8):909-15. PubMed ID: 22869037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Weinstein JJ; van de Giessen E; Rosengard RJ; Xu X; Ojeil N; Brucato G; Gil RB; Kegeles LS; Laruelle M; Slifstein M; Abi-Dargham A
    Mol Psychiatry; 2018 Jun; 23(6):1506-1511. PubMed ID: 28507321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.
    Smith CT; Dang LC; Cowan RL; Kessler RM; Zald DH
    Neuropharmacology; 2016 Sep; 108():394-402. PubMed ID: 27174408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.
    Zakiniaeiz Y; Hillmer AT; Matuskey D; Nabulsi N; Ropchan J; Mazure CM; Picciotto MR; Huang Y; McKee SA; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2019 Dec; 44(13):2205-2211. PubMed ID: 31269510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced striatal dopamine release in schizotypal personality disorder.
    Thompson JL; Rosell DR; Slifstein M; Xu X; Rothstein EG; Modiano YA; Kegeles LS; Koenigsberg HW; New AS; Hazlett EA; McClure MM; Perez-Rodriguez MM; Siever LJ; Abi-Dargham A
    Psychopharmacology (Berl); 2020 Sep; 237(9):2649-2659. PubMed ID: 32572588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Cortical Dopamine Transmission in Cocaine Dependence: A [
    Narendran R; Mason NS; Himes ML; Frankle WG
    Biol Psychiatry; 2020 Nov; 88(10):788-796. PubMed ID: 32507390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study.
    Ceccarini J; Koole M; Van Laere K
    Addict Biol; 2022 May; 27(3):e13167. PubMed ID: 35470551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness?
    Jaworska N; Cox SM; Casey KF; Boileau I; Cherkasova M; Larcher K; Dagher A; Benkelfat C; Leyton M
    PLoS One; 2017; 12(3):e0174219. PubMed ID: 28346539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [
    Girgis RR; Slifstein M; Brucato G; Kegeles LS; Colibazzi T; Lieberman JA; Abi-Dargham A
    Mol Psychiatry; 2021 Jun; 26(6):2504-2513. PubMed ID: 33154566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [
    Sandiego CM; Matuskey D; Lavery M; McGovern E; Huang Y; Nabulsi N; Ropchan J; Picciotto MR; Morris ED; McKee SA; Cosgrove KP
    Neuropsychopharmacology; 2018 Apr; 43(5):1052-1058. PubMed ID: 28944773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine cue-induced dopamine release in the human prefrontal cortex.
    Milella MS; Fotros A; Gravel P; Casey KF; Larcher K; Verhaeghe JA; Cox SM; Reader AJ; Dagher A; Benkelfat C; Leyton M
    J Psychiatry Neurosci; 2016 Aug; 41(5):322-30. PubMed ID: 26900792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.
    Bertolino A; Breier A; Callicott JH; Adler C; Mattay VS; Shapiro M; Frank JA; Pickar D; Weinberger DR
    Neuropsychopharmacology; 2000 Feb; 22(2):125-32. PubMed ID: 10649825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Dorsal Putamen D2/3 Receptor Availability and Amphetamine-Induced Dopamine Release are Related to Poorer Cognitive Function in Recently Abstinent People Who Smoke and Healthy Controls.
    Cheung F; Calakos KC; Gueorguieva R; Hillmer AT; Cosgrove KP; Zakiniaeiz Y
    Nicotine Tob Res; 2024 Jul; 26(8):1038-1044. PubMed ID: 38367211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.